Atlas Trials

EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer

Clinical trial NCT02682082 · TERMINATED

Trial details

NCT number
NCT02682082
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2016-05-27
Primary completion
2019-06-14
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.